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Although noninvasive positive-pressure ventilation(NPPV) is effective in adults,1,2 there are few reportson the use of NPPV in infants. There has been noreport on infants who received NPPV after cardiac
surgery.3 We present the case histories of 2 patients under 1 year
of age who had critical respiratory failure with hypercapnia after
cardiac surgery and who were successfully treated with NPPV
without sedation.4
Clinical Summaries
Patient 1. A 7-month-old female infant (height, 54.1 cm
[4.5 SD]; weight, 3.8 kg [4.1 SD]; human atrial natriuretic
peptide level, 291.7 pg/mL; human brain natriuretic peptide level,
169.0 pg/mL) with cardiac atrial septal defect, pulmonary hyper-
tension, and right-sided diaphragm elevation underwent closure of
the atrial septal defect. On postoperative day (POD) 1, after several
hours of continuous positive airway pressure ventilation at 3 cm
H2O, the arterial oxygen tension (PaCO2) was about 55 mm Hg and
she was extubated. Seven hours after extubation, the PaCO2 rose to
80 mm Hg, tachypnea was present, and the pulmonary artery
pressure increased (Figure 1). We administered NPPV (bilevel
positive-pressure ventilation (ResMed, Sydney, Australia), timed
mode, inspiratory positive airway pressure (PAP) 7.6 cm H2O,
expiratory PAP 3.6 cm H2O, respiratory rate 30 breaths/min; 4
L/min oxygen supply), and the PaCO2 and pulmonary artery pres-
sure decreased (Figure 1). NPPV was administered continuously
from PODs 1 to 14. While she was awake and breathing room air
on POD 17 without NPPV, the PaCO2 was 52.0 mm Hg, PaO2 73.3
mm Hg, pH 7.366, and H2CO3 29.1 mmol/L. With NPPV on POD
19, the transcutaneous PCO2 (TcPCO2) fluctuated periodically. Al-
though polysomnography was not performed, such elevations
would be due to rapid eye movement sleep-related hypoventila-
tion. The degree of fluctuation was small, and the TcPCO2 did not
show an increasing trend. Without NPPV on POD 20, the TcPCO2
fluctuated periodically; however, the TcPCO2 showed an increasing
trend and increased to as high as 95 mm Hg (Figure 2). We decided
to continue NPPV during nighttime hours, and she was discharged
on POD 29 using home NPPV. Home NPPV was successfully
discontinued after 12 months of NPPV, at which time the TcPCO2
during sleep did not exceed 50 mm Hg.
Patient 2. A 4-month-old male infant (height, 57.4 cm [2.4
SD]; weight, 4.39 kg [3.2 SD]; human atrial natriuretic peptide
level, 1110 pg/mL; human brain natriuretic peptide level, 1180
pg/mL) with a single ventricle underwent right ventricular–pulmo-
nary artery conduit and common atrioventricular valve replace-
ment. He was extubated on POD 3 but was reintubated because of
respiratory distress with hypercapnia. On POD 23, while he was
extubated, his TcPCO2 showed an increasing trend with fluctuation.
We administered NPPV for 5 days (timed mode, inspiratory PAP
7.6 cm H2O, expiratory PAP 3.6 cm H2O, respiratory rate 30
breaths/min, with air supply), after which his TcPCO2 stabilized.
He died of severe hydrocephalus on POD 66.
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Figure 1. PaCO2 and PA pressure in patient 1 before and after
extubation. After several hours of 3 cm H2O CPAP, her PaCO2 was
about 55 mm Hg. Seven hours after extubation, her PaCO2 rose to
over 80 mm Hg and her PA pressure also increased. NPPV was
started, and her PaCO2 and PA pressure improved. PaCO2, Arterial
carbon dioxide tension; PA, pulmonary artery; CPAP, continuous
positive airway pressure, FIO2, inspiratory fraction of oxygen;
NPPV, noninvasive positive pressure ventilation; T-mode, timed
mode; RR, respiratory rate; IPAP, inspiratory positive airway
pressure; EPAP, expiratory positive airway pressure; ICU, inten-
sive care unit; POD, postoperative day.
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Discussion
We presented the case histories of 2 infants having respiratory
failure with severe hypercapnia after cardiac surgery. It has been
reported that NPPV is suitable for patients with hypercapnia.2,4
Therefore, we administered NPPV to our patients. If patient 1 had
not received ventilatory support with NPPV, she may have re-
quired intubation for several months. NPPV may be useful in
patients with respiratory failure under 1 year of age after cardiac
surgery, as in patients with respiratory disturbance after undergo-
ing liver transplantation.4
We administered NPPV in the timed mode for our infant
patients. Essouri and associates3 used inspiratory pressure support
with positive end-expiratory pressure, the so-called spontaneous
mode. We believe that the timed mode is appropriate for infants
under 2 years of age whose respiratory rate often becomes greater
than 60 breaths/min. Further studies are needed to determine which
mode is appropriate for infants under 1 or 2 years.
We have administered NPPV to 20 patients under 2 years of
age with respiratory failure, including the current 2 patients and
those in our previous report,4 and the success rate was 80%
(16/20). In the successful cases, the arterial oxygen saturation
increased to over 95% with NPPV and supplemental oxygen
within 10 minutes. In the cases in which the treatment failed, the
patients were in distress and their arterial oxygen saturation re-
mained below 95% despite NPPV with 10 L/min supplemental
oxygen.
We performed nocturnal TcPCO2 monitoring with and without
NPPV, which clearly showed the effectiveness of NPPV during
sleep. TcPCO2 monitoring during sleep with and without NPPV
may be useful for determining whether NPPV is necessary during
sleep in infants.
Most infants with diaphragmatic paralysis recover over the next
several months.5 However, surgical plication of the diaphragm is
necessary in some cases. Expectant management is generally advo-
cated for at least 2 months before performing surgical plication.5 The
present cases suggest that NPPV may obviate the need for surgical
plication, even in infants who have undergone cardiac surgery.
Considering the usefulness and disadvantages of NPPV,1
NPPV may be effective in infants who have respiratory failure
after cardiac surgery.
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Figure 2. TcPCO2 in patient 1 with or without NPPV.
Without NPPV on postoperative day (POD) 20, the
TcPCO2 fluctuated periodically and showed an in-
creasing trend. With NPPV on POD 19, the TcPCO2 also
fluctuated periodically; however, the degree of fluc-
tuation was small and the TcPCO2 did not show an
increasing trend. The patient was believed to have
rapid eye movement sleep-related hypoventilation.
This demonstrated the effectiveness of NPPV. TcPCO2,
Transcutaneous PCO2; NPPV, noninvasive positive-
pressure ventilation.
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